OnKure Therapeutics


OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

Employees

11-50

Links


Org chart

Anthony D. Piscopio
CEO & President
Collapse
Jennifer Diamond
Chief Medical Officer
Duncan Walker
Chief Development Officer
Duncan W.
Chief Development Officer (cdo)
Samuel Agresta
Chief Medical Officer
Dylan Hartley
Chief Scientific Officer

Board & advisors

Susan Bates
Scientific Advisor
Lia Gore
Scientific Advisor
Xuedong Liu
Scientific Advisor
Keith Flaherty
Scientific Advisor
Kevin Koch
Scientific Advisor
Pamela Munster
Scientific Advisor